Fluidigm Corporation Commercial Tutorial

  • Registration Closed

Immune monitoring studies, especially in the age of COVID-19 disease, require cytometry assays that:

  • are quick to implement with an easy workflow;
  • have fixation embedded early in sample processing;
  • are high parameter to ensure the most information possible per cell;
  • have a streamlined, reproducible and unbiased data analysis pipeline; and
  • have proven reproducibility when performed at distant sites.

The Maxpar® Direct™ Immune Profiling System designed for use on Helios™, a CyTOF system, meets all these criteria. Frederik De Smet will present how the Maxpar® Direct™ Immune Profiling Assay™ and Maxpar® Pathsetter™ software are being used in the COvid-19 Advanced Genetic and Immunologic Sampling (COntAGIouS) clinical research study (NCT04327570) to gain an in-depth characterization of the dynamic host immune response to SARS-CoV-2. Noah Saederup will provide background information on the Maxpar Direct family of products, their unique benefits for clinical research studies and data from a multi-site study using the Maxpar Direct Immune Profiling System.

Noah Saederup, PhD

Senior Product Manager, Maxpar Reagents, Fluidigm

Frederik De Smet, PhD

Assistant Professor, University of Leuven, Belgium

Theresa Royer

Ofir Goldberg, PhD

Director, Corporate Development, Fluidigm

Components visible upon registration.

NOTE: This event is held in Eastern Daylight time (GMT-4)